WASHINGTON — In the fall of 2024, America’s measles situation appeared to be worsening but manageable: 285 confirmed cases for the full year, a number that prompted concern but not alarm. A year later, 2025 closed with 2,288 cases, the highest total in recent memory. Now, with just six months of 2026 accounted for, the country has already recorded 2,134 cases, roughly 93 percent of last year’s entire count, and the summer travel and gathering season, the period that historically amplifies every contagious disease, has barely begun.
The latest C.D.C. data, updated June 26, show the sharpest acceleration in measles transmission the United States has seen in decades. Thirty separate outbreaks have been confirmed this year, with 1,982 of the 2,134 total cases, 93 percent, linked to outbreak clusters rather than isolated travel-associated infections. The cases span 41 states and 41 jurisdictions.
What makes the number more troubling than it appears in isolation is the arithmetic that produced it. In 2024, 285 Americans contracted measles. In 2026, the same figure was exceeded in the first weeks of January. The country is recording more than 350 cases per month on average, a rate that, sustained for the remaining six months of the year, would produce a full-year total roughly twice last year’s record. The C.D.C. has not projected a final tally, and whether the outbreak continues at this pace depends on factors that cannot yet be measured.
The driver is not mysterious. Vaccination coverage among American kindergartners, measured annually by the C.D.C., has declined steadily over the past five years. During the 2019–2020 school year, 95.2 percent of entering kindergartners had received both required doses of the measles-mumps-rubella vaccine. By the 2024–2025 school year, that figure had dropped to 92.5 percent. The gap sounds small, fewer than three percentage points, but it translates to approximately 286,000 kindergartners entering American classrooms each year without full measles protection. In a disease where a single infected person can expose up to 18 others, that gap widens very fast.
Of the 2,134 cases recorded through late June, 89 percent involved people who were unvaccinated or whose vaccination status was unknown. Seven percent had received one dose of MMR vaccine; four percent had received two. That profile has held consistent across all 30 outbreaks, suggesting the driving force is not a failure of vaccine supply or access in any single community, but a broader, sustained pattern of under-immunization across multiple populations and geographies simultaneously.
The July 4 holiday weekend concentrates the conditions under which measles spreads most efficiently. Air travel, crowded fireworks venues, large family gatherings, and celebrations that mix vaccinated and unvaccinated children from multiple regions create the exposure conditions that seed new outbreak clusters. Epidemiologists have documented this pattern across previous measles seasons: case counts regularly tick upward in the weeks following major holidays and summer travel peaks. This year, the baseline entering the holiday is already close to a modern record.
Globally, the picture is even more stark. According to the W.H.O., measles killed 95,000 people worldwide in 2024, almost all of them unvaccinated children under five in low-income countries where vaccine access remains inconsistent. The same agency credits measles vaccination programs with preventing approximately 59 million deaths since 2000. The United States, which formally eliminated endemic measles transmission in 2000, now faces the prospect of sustained community spread re-establishing itself in communities where vaccination rates have fallen below the 95 percent threshold that blocks transmission.
Measles is not the only contagious illness pressing on American communities this summer. A record West Nile season, driven by an early mosquito season in the South and West, is producing the highest case counts at this point in the summer in two decades. A parallel Cyclospora parasite outbreak has sickened hundreds across 17 states, with no recalled product and no identified source. The public health system is managing multiple simultaneous pressures at a moment when official messaging on vaccines has been widely questioned.
The C.D.C. has not issued specific guidelines for the holiday weekend beyond its standing advisories: confirm vaccination status before travel, particularly for children under five and adults born after 1957 who may lack documentation of immunity. Two doses of MMR vaccine are considered 97 percent effective against measles infection. Adults born before 1957 are generally considered immune due to natural exposure before widespread vaccination. The cost of a two-dose MMR series for an uninsured child runs roughly $180 to $220 at retail pharmacy prices, though it is covered without cost-sharing under most insurance plans and available at no cost through the federal Vaccines for Children program.
Whether 2026 closes with a case count below last year’s 2,288, level with it, or substantially above it will depend on what happens in the outbreaks already running across 41 states. Several of those clusters have not yet peaked; the C.D.C. does not project when they will. What is not uncertain is where this trend began. Measles vaccination rates in the United States have been falling for five years. The cases now unfolding are the arithmetic consequence of that slide.
